N/A
N=162
Comparison of Intravascular Uptake and Pain Perception During Epidural Injection Using 22 Gauge vs 25 Gauge Needle
Pain · Needle Injury
Bottom Line
View on ClinicalTrials.gov: NCT04350307 ↗Enrolled (actual)
162
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: Intravascular Uptake — 5.9; 7.1 percentage of total number of needle
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- 22-gauge needle (Device); 25-gauge needle (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Yale University
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intravascular Uptake |
5.9; 7.1 | — |
| SECONDARY Patient Reported Pain |
3.46; 3.13 | — |
Summary
The aim of the study was to quantify the difference between a 22-gauge needle and 25-gauge needle during lumbosacral epidural steroid injection in regards to intravascular uptake and pain perception. There is the notion that a smaller gauge needle may lead to less intravascular uptake and less pain.
Eligibility Criteria
Inclusion Criteria
- patients with low back pain and/or radicular pain,
- patients scheduled for lumbosacral TFESI.
Exclusion Criteria
- patients with contrast/local anesthetic allergy,
- patients with pregnancy, coagulopathy, systemic infection, and inability to provide informed consent,
- vulnerable patient population including prisoners,
- patients with severe anxiety,
- patients with prior lumbar surgery,
- age 40.
Data sourced from ClinicalTrials.gov (NCT04350307). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.